Ypsomed said the YpsoLoop platform integrates into existing production environments. This supports a transition toward more ...

Insulet (Nasdaq:PODD) announced today that it appointed Robert "Robbie" L. Huffines to its board of directors.

Abbott (NYSE:ABT) today shared that it made its Lingo biowearable device available for purchase at Walmart stores.

Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain ...

On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.

MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin ...

The Swiss drug delivery device maker selected Holly Springs, North Carolina for the location. It plans to invest ...

Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.

A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.

Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to traditional corneal cross-linking procedures. Epoxia offers an advancement in corneal cross-linking ...